MedCity News January 13, 2022
Providers, payers, and life sciences companies have a lot of room for growth using AI, and investors participating in JPM will continue to focus on companies that recognize this and act on it.
A battle over establishing trust and influence with patients and consumers is raging in healthcare. This was a topic that underscored many of the thousands of Zoom meetings among investors and industry insiders that took place this week surrounding J.P. Morgan’s 40th Annual Healthcare Conference. Like last year, the meetings were virtual, but the investment that will drive healthcare forward is very tangible.
The ongoing trend of consumerism and the use of technology in healthcare is the context for this competition. Patients have more choices in healthcare,...